Alkyne hexacarbonyl dicobalt complexes in medicinal chemistry and drug development

Bibliography

• Galanski M, Jakupec MA, Keppler BK. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches. Curr Med Chem 2005;12:2075-94
   PubMed Web of Science ®Google Scholar
• Jakupec MA, Galanski M, Keppler BK. Tumour-inhibiting platinum complexes: state of the art and future perspectives. Rev Physiol Biochem Pharmacol 2003;146:1-53
   PubMed Web of Science ®Google Scholar
• Ott I, Gust R. Non-platinum complexes as anticancer drugs. Arch Pharm Chem Life Sci 2007;340:117-26
   PubMed Web of Science ®Google Scholar
• Meggers E. Exploring biologically relevant chemical space with metal complexes. Curr Opin Chem Biol 2007;11:287-92
   PubMed Web of Science ®Google Scholar
• Hambley TW. Metal-based therapeutics. Science 2007;318:1392-3
   PubMed Web of Science ®Google Scholar
• Hartinger CG, Zorbas-Seifried S, Jakupec MA, et al. From bench to bedside: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). J Inorg Biochem 2006;100:891-904
   PubMed Web of Science ®Google Scholar
• Ware DC, Palmer BD, Wilson WR, et al. Hypoxia selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards. J Med Chem 1993;36:1839-46
   PubMed Web of Science ®Google Scholar
• Ware DC, Palmer BD, Brothers BJ, et al. Bis-tropolonato derivatives of cobalt (III) complexes of aliphatic bidentate nitrogen mustards as potential hypoxia-selective cytotoxins. J Inorg Biochem 1997;68:215-24
   PubMed Web of Science ®Google Scholar
• Failes TW, Hambley TW. Models of hypoxia activated prodrugs: cobalt(III) complexes of hydroxamates. Dalton Trans 2006;1895-901
   PubMed Web of Science ®Google Scholar
• Failes TW, Cullinane C, Diakos CI. Studies of a cobalt(III) complex of the MMP inhibitor marimastat: a potential hypoxia-activated prodrug. Chem Eur J 2007;13(10):2974-82
   PubMed Web of Science ®Google Scholar
• Teicher BA, Jacobs JL, Cathcart CN, et al. Some complexes of cobalt(III) and iron(III) are radiosensitizers of hypoxic EMT6 cells. Radiat Res 1987;109(1):36-46
   PubMed Web of Science ®Google Scholar
• Ahn GO, Ware DC, Denny WA, Wilson WR. Optimization of the auxiliary ligand shell of cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs. Radiat Res 2004;162(3):315-25
   PubMed Web of Science ®Google Scholar
• Ahn GO, Botting KJ, Patterson AV, et al. Radiolytic and cellular reduction of a novel hypoxia-activated cobalt(III) prodrug of chloromethylbenzindoline DNA minor groove alkylator. Biochem Pharmacol 2006;71(12):1683-94
   PubMed Web of Science ®Google Scholar
• Hall MD, Failes TW, Yamamoto N, Hambley TW. Bioreductive activation and drug chaperoning in cobalt pharmaceuticals. Dalton Trans 2007;3983-90
   PubMed Web of Science ®Google Scholar
• Liu Y, Pak JK, Schmutz P, et al. Amino acids labelled with [99mTc(CO)3]+ and recognized by the L-type amino acid transporter LAT1. J Am Chem Soc 2006;128:15996-7
   PubMed Web of Science ®Google Scholar
• Agorastos N, Borsig L, Renard A, et al. Cell-specific and nuclear targeting with [M(CO)3]+ (M=99mTc, Re)-based complexes conjugated to acridine orange and bombesin. Chemistry 2007;13:3842-52
   PubMed Web of Science ®Google Scholar
• Smalley KSM, Contractor R, Haass N, et al. An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. Cancer Res 2007;67:209-17
   PubMed Web of Science ®Google Scholar
• Johnson TR, Mann BE, Clark JE, et al. Metal carbonyls: a new class of pharmaceuticals? Angew Chem Int Ed 2003;42:3722-9
   PubMed Web of Science ®Google Scholar
• Alberto R, Motterlini R. Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes. Dalton Trans 2007;17:1651-60
   PubMed Web of Science ®Google Scholar
• Schlawe D, Majdalani A, Velcicky J, et al. Iron-containing nucleoside analogues with pronounced apoptosis-inducing activity. Angew Chem Int Ed Engl 2004;43:1731-4
   PubMed Web of Science ®Google Scholar
• Greenfield H, Sternberg HW, Friedel RA, et al. Acetylenic dicobalt hexacarbonyls. Organometallic compounds derived from alkynes and dicobalt octacarbonyl. J Am Chem Soc 1956;78:120-4
   Web of Science ®Google Scholar
• Green JR. Chemistry of propargyldicobalt cations: recent developments in the Nicholas and related reactions. Curr Org Chem 2001;5:809-26
   Web of Science ®Google Scholar
• Gregson D, Howard JAK. The X-ray single crystal and molecular structures of [Co2(CO)6C2R2] for R=Ph(I), CO2Me(II) (292 K) and R=But(III) (200 K). Acta Cryst 1983;C39:1024-7
   Google Scholar
• Schmidt K, Jung M, Keilitz R, et al. Acetylenehexcarbonyldicobalt complexes, a novel class of antitumor drugs. Inorg Chim Acta 2000;306:6-16
   Web of Science ®Google Scholar
• Omae I. Three characteristic reactions of organocobalt compounds in organic synthesis. Appl Organomet Chem 2007;21:318-44
   Web of Science ®Google Scholar
• Hyama T, Nishide K, Saimoto H, et al. Chem Abstr 1987;107:229145b
   Google Scholar
• Jung M, Kerr DE, Senter PD. Bioorganometallic chemistry: synthesis and antitumor activity of cobalt carbonyl complexes. Arch Pharm 1997;330(6):173-6
   PubMed Web of Science ®Google Scholar
• Roth T, Eckert C, Fiebig HH, et al. Comparative action of cobalt carbonyl complexes on cancer cells using human tumor xenografts. Anticancer Res 2002;22(4):2281-4
   PubMed Web of Science ®Google Scholar
• Ott I, Kircher B, Gust R. Investigations on the effects of cobalt-alkyne complexes on leukemia and lymphoma cells: cytotoxicity and cellular uptake. J Inorg Biochem 2004;98:485-9
   PubMed Web of Science ®Google Scholar
• Ott I, Schmidt K, Kircher B, et al. Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action. J Med Chem 2005;48:622-9
   PubMed Web of Science ®Google Scholar
• Ott I, Koch T, Shorafa H, et al. Synthesis, cytotoxicity, cellular uptake and influence on eicosanoid metabolism of cobalt-alkyne modified fructoses in comparison to auranofin and the cytotoxic COX-inhibitor Co-ASS. Org Biomol Chem 2005;3:2282-6
   PubMed Web of Science ®Google Scholar
• Ott I, Abraham A, Schumacher P, et al. Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyl dicobalt complexes with the tyrosine kinase inhibitor imatinib. J Inorg Biochem 2006;100:1903-6
   PubMed Web of Science ®Google Scholar
• Sergeant CD, Ott I, Sniady A, et al. Metallo-nucleosides: synthesis and biological evaluation of hexacarbonyl dicobalt 5-alkynyl-2′-deoxyuridines. Org Biomol Chem 2008;6:73-80
   PubMed Web of Science ®Google Scholar
• Ulrich CM, Bigler J, Potter JD, et al. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 2006;6:130-40
   PubMed Web of Science ®Google Scholar
• Ott I, Gust R. Stability, protein binding and thiol interaction studies on [2-acetoxy-(2-propynyl)benzoate]hexacarbonyl dicobalt. Biometals 2005;18:171-7
   PubMed Web of Science ®Google Scholar
• Etheve-Quelquejieu M, Tranchier J-P, Rose-Munch F, et al. η6-(Arene)tricarbonylchromium and manganese complexes linked to 2′-deoxyuridine. Organometallics 2007;26:5727-30
   Web of Science ®Google Scholar
• Neukamm MA, Pinto A, Metzler-Nolte N. Synthesis and cytotoxicity of a cobaltcarbonyl-alkyne enkephalin bioconjugate. Chem Commun 2008;232-4
   PubMed Web of Science ®Google Scholar
• Jaouen G, Vessieres A, Top S, et al. Metal carbonyl fragments as a new class of markers in molecular biology. J Am Chem Soc 1985;107:4778-80
   Web of Science ®Google Scholar
• Salmain M, Vessieres A, Jaouen G, et al. Fourier transform infrared spectroscopic method for the quantitative trace analysis of transition metal carbonyl-labeled bioloigands. Anal Chem 1991;63:2323-9
   PubMed Web of Science ®Google Scholar
• Metzler-Nolte N. Labeling of biomolecules for medicinal applications: bioorganometallic chemistry at its best. Angew Chem Int Ed Engl 2001;40(6):1040-3
   PubMed Web of Science ®Google Scholar
• Philomin V, Vessieres A, Jaouen G. New applications of carbonylmetalloimmunoassay (CMIA): a nonradioisotopic approach to cortisol assay. J Immunol Methods 1994;171:201-10
   PubMed Web of Science ®Google Scholar
• Philomin V, Vessieres A, Gruselle M, et al. Synthesis of cobalt carbonyl complexes of cortisol and testosterone. Study of their recognition by specific polyclonal antibodies. Bioconjug Chem 1993;4(6):419-24
   PubMed Web of Science ®Google Scholar
• Salmain M, Vessieres A, Butler IS, et al. (N-Succinimidyl-4-pentynoate)hexacarbonyl dicobalt: a transition metal carbonyl complex having similar uses to the Bolton-Hunter reagent. Bioconjug Chem 1991;2:13-5
   PubMed Web of Science ®Google Scholar
• Varenne A, Vessieres A, Salmain M, et al. Production of specific antibodies and development of a non-isotopic immunoassay for carbamazepine by carbonyl metallo-immunoassay (CMIA) method. J Immunol Methods 1995;186(2):195-204
   PubMed Web of Science ®Google Scholar
• Varenne A, Vessieres A, Salmain M, et al. Quantitative analysis of mixtures of metal-carbonyl complexes by Fourier transform infrared spectroscopy: application to the simultaneous double immunoassay of antiepileptic drugs by the noisotopic carbonyl metalloimmunoassay method. Anal Biochem 1996;242(2):172-9
   PubMed Web of Science ®Google Scholar
• Salmain M, Vessieres A, Varenne A, et al. A new application of bioorganometallics: the first simultaneous triple assay by the carbonylmetalloimmunoassay (CMIA) method. J Organomet Chem 1999;589(1):92-7
   Web of Science ®Google Scholar
• Vessieres A, Salmain M, Brossier P, et al. Carbonylmetalloimmunoassay: a new application for Fourier transform infrared spectroscopy. J Pharm Biomed Anal 1999;21(3):625-33
   PubMed Web of Science ®Google Scholar
• Varenne A, Salmain M, Brisson C, et al. Transition metal carbonyl labeling of proteins. A novel approach to a solid-phase two-site immunoassay using Fourier transform infrared spectroscopy. Bioconjug Chem 1992;3:471-6
   PubMed Web of Science ®Google Scholar
• Salmain M, Fischer-Durand N, Cavalier L, et al. Transition metal carbonyl labeling of biotin and avidin for use in solid-phase carbonyl metallo immunoassay. Bioconjug Chem 2002;13(3):693-8
   PubMed Web of Science ®Google Scholar
• Vessieres A, Top S, Vaillant C, et al. Estradiols modified by metal carbonyl clusters as suicide substrates for the study of receptor proteins: application to the estradiol receptor. Angew Chem Int Ed Engl 1992;31(6):753-5
   Web of Science ®Google Scholar
• Osella D, Galeotti F, Cavigioloi G, et al. The hexacarbonyl(ethyne)dicobalt unit: an androgen tag. Helvetica Chim Acta 2002;85:2918-25
   Web of Science ®Google Scholar
• Top S, El Hafa H, Vessieres A, et al. Novel estradiol derivatives labeled with Ru, W and Co complexes. Influence on hormone-receptor affinity of several organometallic groups at the 17α-position. Chem Eur J 2002;8(22):5241-9
   PubMed Web of Science ®Google Scholar
• Biotesys gmbh. Enzyme-linked immunoassay kit for identifying oxidized biomacromolecules, useful for early diagnosis of e.g. neurodegenerative disease, uses antibodies against dinitrophenylhydrazine for detecting carbonyl compounds. FR2856798 (2004)
   Google Scholar
• Ire Celltarg SA. Affinity markers for hormonal steroid receptors, their use in hormonoradio therapy and as imaging agents of hormone-dependent cancers. EP345153 (1989)
   Google Scholar
• Centre Nat Rech Scient. Organometallic complexes of estrogens and their application to the determination of hormone receptors. US4983646 (1991)
   Google Scholar
• Centre Nat Rech Scient. Organometallic complexes of estrogens and their application to the determination of hormone receptors. US4656142 (1987)
   Google Scholar
• Centre Nat Rech Scient. Organometallic complexes of estrogens and their use in the determination of hormone receptors. EP0105785 (1984)
   Google Scholar
• Centre Nat Rech Scient. Organic metal complex of estrogen and application to hormone receptor determination. JP59080695 (1984)
   Google Scholar
• Centre Nat Rech Scient. Organometallic complexes of estrogens and their use in the determination of hormone receptors. FR2533570 (1984)
   Google Scholar
• Centre Nat Rech Scient. Organometallische Komplexe von Oestrogenen und ihre Anwendung fuer die Bestimmung von Hormonrezeptoren. AT32727T (1988)
   Google Scholar
• Organometallic complexes of estrogens and use for the assay of hormone receptors. CA1234037 (1988)
   Google Scholar
• Centre Nat Rech Scient. Organometallic oestrogen complexes and their use in the assay of the hormonal receptors. CA1220469 (1987)
   Google Scholar
• Roussel Uclaf. Organometallic complexes of steroidal products with an affinity for progestogen and glucocorticoid receptors and their application to the assay of hormone receptors. FR2592047 (1987)
   Google Scholar
• Centre Nat Rech Scient. Infrared immunological dosing. WO8807684 (1988)
   Google Scholar
• Centre Nat Rech Scient. Dosage immunologique infrarouge. FR2613490 (1988)
   Google Scholar
• Centre Nat Rech Scient. Infrared immunological dosing. EP308473 (1989)
   Google Scholar
• Centre Nat Rech Scient. Cold marking of molecules of peptidic or proteinic nature. WO8910372 (1989)
   Google Scholar
• Centre Nat Rech Scient. Marquage froid de molecules de nature peptidique ou proteique. FR2630547 (1989)
   Google Scholar
• Centre Nat Rech Scient. Cold marking of molecules of peptidic or proteinic nature. EP412104 (1991)
   Google Scholar
• Centre Nat Rech Scient. New types of cold bioprobes comprising a cluster of alcyne-carbonyle metal. WO8805439 (1988)
   Google Scholar
• Centre Nat Rech Scient. New types of cold bioprobes comprising a cluster of alcyne-carbonyle metal. FR2610113 (1988)
   Google Scholar
• Centre Nat Rech Scient. New types of cold bioprobes comprising a cluster of alcyne-carbonyle metal. EP299045 (1989)
   Google Scholar
• JP01502663
   Google Scholar
• Centre Nat Rech Scient. Cold marking of molecules of peptidic or proteinic nature. WO8910372 (1989)
   Google Scholar
• Centre Nat Rech Scient. Marquage froid de molecules de nature peptidique ou proteique. FR2630547 (1989)
   Google Scholar
• Debreczeni JE, Bullock AN, Atilla GE, et al. Ruthenium half-sandwich complexes bound to the protein kinase Pim-1. Angew Chem Int Ed 2006;45:1580-5
   PubMed Web of Science ®Google Scholar